Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr S...
Saved in:
Main Authors: | Bosani M, Ardizzone S, Porro GB |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologic targeting in the treatment of inflammatory bowel diseases
by: Matteo Bosani, et al.
Published: (2009) -
Adalimumab for the treatment of Crohn’s disease
by: Andrea Cassinotti, et al.
Published: (2008) -
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
by: Marafini I, et al.
Published: (2020) -
Editorial: Game Changers in Inflammatory Bowel Diseases
by: Anita Bálint, et al.
Published: (2021) -
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
by: Al Sulais E, et al.
Published: (2020)